Latest News
A recent study has demonstrated a significant decrease in cases of HPV infections in England since the introduction of a bivalent vaccine in 2008.
A genetic test could aid the identification of men with prostate cancer who are most likely to benefit from immunotherapy.
A study has discovered the first genetic marker that can distinguish between aggressive versus benign bone tumors.
Journal Articles
Discover the case of nivolumab-induced synchronous occurrence of myositis and hypothyroidism in a patient with squamous cell lung cancer in this article from the impactful journal Immunotherapy.
In this article from CNS Oncology discover two case reports of adenocarcinoma and breast carcinoma that metastasized into an intracranial meningioma.
In this review article find out which treatment plan is most appropriate for different groups of acute lymphoblastic leukemia patients.
Brain and neurologic
Glioblastoma vaccine yields promising interim survival results in Phase III trial
Intracranial meningioma with carcinoma tumor-to-tumor metastasis: two case reports
Children with incurable brain tumors could benefit from adult therapy
Breast
TAILORx: a practice-changing breast cancer trial
Personalized immunotherapy leads to complete response in metastatic breast cancer patient
ASCO18: Early-stage breast cancer patients could be spared chemotherapy, TAILORx trial shows
Colorectal
ASCO18: PRODIGE 7 demonstrates that HIPEC may not be necessary for CRC patients
ASCO18: MSI-H tumor patients more likely to have Lynch Syndrome, genomic study demonstrates
Endocrine
ASCO18: Is surgery necessary for advanced kidney cancer?
Nivolumab + ipilimumab combo approved as first-line treatment for advanced renal cell carcinoma
Born to be bad: researchers identify the genetic roots of ‘killer' kidney cancers
Gastrointestinal
New blood test could detect eight types of cancer
Study links NF1 mutations to GIST tumors, highlighting the need for genetic testing
Genitourinary
NICE approves atezolizumab for advanced bladder cancer patients on the NHS
Breakthrough method to diagnose prostate cancer developed
Researchers uncover 80 potential ways of targeting prostate cancer
Gynecologic
Vaccine success for cervical cancer: study reports fall in HPV infections
Cause of resistance to olaparib and other PARP inhibitors identified
Head and neck
The importance of a multidisciplinary team in the care of head and neck cancer
The importance of sentinel lymph node biopsies in the diagnosis of head and neck cancer
ASCO18: High dose of Nexium® with aspirin reduces risk of developing esophageal cancer
Hematologic
Landmark paper sets out ‘unified theory’ for cause of acute lymphoblastic leukemia
Management of older adults with acute lymphoblastic leukemia: challenges & current approaches
Scientific and regulatory challenges in development of CAR-T therapy for solid tumors
Lung
First-of-its-kind NSCLC vaccine moves into Phase I trial
ASCO18: Early-stage lung cancer - could blood tests be used as a potential detection tool?
Pancreatic
ASCO18: Preoperative chemoradiotherapy improves survival time for patients with pancreatic cancer
Smartphone app shows promise for pancreatic cancer detection
Prostate
Prostate cancer test shows promise for identifying high-risk patients
Rare tumors
Osteoblastoma genetic marker shows promise for identifying aggressive tumors
Skin
AACR 2018: highlights and the biggest news headlines
AACR 2018: Positive data announced for KEYTRUDA® in adjuvant melanoma
